Disease
|
Drug/Important Bio-Agent (IBA)
6 | Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2023
-
01/2020 |
2 | Biomarkers (Surrogate Marker)IBA
11/2021
-
01/2021 |
1 | MethylprednisoloneFDA LinkGeneric
01/2023 |
1 | Rituximab (Mabthera)FDA Link
01/2020 |
1 | Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 |
1 | 2,2',3,3',4,4',5,5',6-nonabromodiphenyl etherIBA
01/2018 |
1 | Flame Retardants (Fire Retardants)IBA
01/2018 |
1 | Halogenated Diphenyl EthersIBA
01/2018 |
1 | 2,2',3,3',4,4',5,6,6'-nonabromodiphenyl etherIBA
01/2018 |
|
Therapy/Procedure
|